3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
157
Carcinoma, Intraductal, Noninfiltrating
16
Breast Carcinoma In Situ
12
Neoplasm Metastasis
9
Ovarian Neoplasms
7
Breast Neoplasms, Male
7
Neoplasms
4
Prostatic Neoplasms
3
Inflammatory Breast Neoplasms
3
Glioblastoma
3
Breast Cancer Female
3
Urinary Bladder Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Obesity
2
Infertility
2
Hot Flashes
2
Fibroadenoma
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
ER+ Breast Cancer
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Sleep Wake Disorders
1
Sexuality
1
Risk Reduction Behavior
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Primary Breast Cancer
1
Interventions
Tamoxifen
2
palbociclib
1
exemestane
1
elacestrant
1
Letrozole
1
Fulvestrant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
ER+ Breast Cancer
×
Tamoxifen
×
Clear all
NCT04985266
2024-12-05
TRAK-ER
Royal Marsden NHS Foundation Trust
Phase 2
Recruiting
1,100 enrolled
NCT05525481
2023-11-01
PREDICTAM
Erasmus Medical Center
Phase 4
Unknown
100 enrolled